These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 17966977
21. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D. Int J Oncol; 2008 Feb; 32(2):475-80. PubMed ID: 18202771 [Abstract] [Full Text] [Related]
22. Multitargeted therapy of cancer by ellagitannins. Heber D. Cancer Lett; 2008 Oct 08; 269(2):262-8. PubMed ID: 18468784 [Abstract] [Full Text] [Related]
23. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay. Bialonska D, Kasimsetty SG, Khan SI, Ferreira D. J Agric Food Chem; 2009 Nov 11; 57(21):10181-6. PubMed ID: 19824638 [Abstract] [Full Text] [Related]
27. International multidimensional authenticity specification (IMAS) algorithm for detection of commercial pomegranate juice adulteration. Zhang Y, Krueger D, Durst R, Lee R, Wang D, Seeram N, Heber D. J Agric Food Chem; 2009 Mar 25; 57(6):2550-7. PubMed ID: 19249817 [Abstract] [Full Text] [Related]
28. Pomegranate as a functional food and nutraceutical source. Johanningsmeier SD, Harris GK. Annu Rev Food Sci Technol; 2011 Mar 25; 2():181-201. PubMed ID: 22129380 [Abstract] [Full Text] [Related]
30. Nutritive and antioxidative potential of fresh and stored pomegranate industrial byproduct as a novel beef cattle feed. Shabtay A, Eitam H, Tadmor Y, Orlov A, Meir A, Weinberg P, Weinberg ZG, Chen Y, Brosh A, Izhaki I, Kerem Z. J Agric Food Chem; 2008 Nov 12; 56(21):10063-70. PubMed ID: 18925742 [Abstract] [Full Text] [Related]
31. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Rosenblat M, Hayek T, Aviram M. Atherosclerosis; 2006 Aug 12; 187(2):363-71. PubMed ID: 16226266 [Abstract] [Full Text] [Related]
32. Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial. González-Sarrías A, García-Villalba R, Romo-Vaquero M, Alasalvar C, Örem A, Zafrilla P, Tomás-Barberán FA, Selma MV, Espín JC. Mol Nutr Food Res; 2017 May 12; 61(5):. PubMed ID: 27879044 [Abstract] [Full Text] [Related]
34. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Loren DJ, Seeram NP, Schulman RN, Holtzman DM. Pediatr Res; 2005 Jun 12; 57(6):858-64. PubMed ID: 15774834 [Abstract] [Full Text] [Related]
35. Pomegranate fruit components modulate human thrombin. Cuccioloni M, Mozzicafreddo M, Sparapani L, Spina M, Eleuteri AM, Fioretti E, Angeletti M. Fitoterapia; 2009 Jul 12; 80(5):301-5. PubMed ID: 19358882 [Abstract] [Full Text] [Related]
36. Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients. Wu PT, Fitschen PJ, Kistler BM, Jeong JH, Chung HR, Aviram M, Phillips SA, Fernhall B, Wilund KR. J Med Food; 2015 Sep 12; 18(9):941-9. PubMed ID: 25826143 [Abstract] [Full Text] [Related]
37. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. Bialonska D, Kasimsetty SG, Schrader KK, Ferreira D. J Agric Food Chem; 2009 Sep 23; 57(18):8344-9. PubMed ID: 19705832 [Abstract] [Full Text] [Related]
38. Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study. Balbir-Gurman A, Fuhrman B, Braun-Moscovici Y, Markovits D, Aviram M. Isr Med Assoc J; 2011 Aug 23; 13(8):474-9. PubMed ID: 21910371 [Abstract] [Full Text] [Related]
39. The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome. Selma MV, González-Sarrías A, Salas-Salvadó J, Andrés-Lacueva C, Alasalvar C, Örem A, Tomás-Barberán FA, Espín JC. Clin Nutr; 2018 Jun 23; 37(3):897-905. PubMed ID: 28347564 [Abstract] [Full Text] [Related]